---
$id: https://graph.org.ai/products/commodity/51162741
$type: Product
source: UNSPSC
code: "51162741"
title: "Taurosteine"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Taurosteine

**UNSPSC Code**: 51162741
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mucolytic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 43A07PH183. European Medicines Agency schedules Taurosteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10840MIG. Taurosteine generally arises in the molecular formula C7H9NO4S2. The term TAUROSTEINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 5, no. 3 1991, list 31.) TAUROSTEINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule taurosteine under HS 29349990 and SITC 51579. As of Q4 2014, TAUROSTEINE remains US FDA's Preferred Term for this commodity. Taurosteine bears US NLM identifiers UMLS ID C2699896 and NCI Concept Code C74549. SMILES: S(=O)(=O)(O)CCNC(=O)C1SCCC1.

